Spinal pharmacology of tactile allodynia in diabetic rats
- 1 December 1997
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 122 (7), 1478-1482
- https://doi.org/10.1038/sj.bjp.0701538
Abstract
1. Rats develop tactile allodynia to stimulation of the plantar surface of the hindpaw with von Frey filaments within days of the onset of streptozotocin-induced diabetes. This is prevented by insulin and alleviated by systemic lignocaine, but the aetiology is unknown. 2. Using indwelling lumbar intrathecal catheters to deliver pharmacological agents, we have investigated whether tactile allodynia in streptozotocin-diabetic rats is dependent on mechanisms associated with spinal sensitization, by assessing the efficacy of agents that inhibit specific components of spinal nociceptive processing. 3. Dose-dependent inhibition of tactile allodynia in diabetic rats was noted with the N-type calcium channel antagonist SNX 239, the alpha2-adrenoceptor agonist dexmedetomidine, the mu-opioid receptor agonist morphine, the N-methyl-D-aspartate (NMDA) receptor antagonist AP5 and the non-NMDA receptor antagonist NBQX. 4. No effect on tactile allodynia was noted after intrathecal administration of the nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME), the cyclo-oxygenase inhibitor ketorolac, the L-type calcium channel inhibitor diltiazem or any vehicle. 5. These data suggest that the tactile allodynia of diabetic rats involves spinal glutamatergic pathways but is not associated with spinal release of nitric oxide or prostaglandins.Keywords
This publication has 36 references indexed in Scilit:
- The effect of an aldose reductase inhibitor (Sorbinil®) on diabetic neuropathy and neural function of the retina: a double-blind studyActa Neurologica Scandinavica, 2009
- A Selective N-Type Calcium Channel Antagonist Reduces Extracellular Glutamate Release and Infarct Volume in Focal Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 1995
- Calcium signal prolongation in sensory neurones of mice with experimental diabetesNeuroReport, 1995
- Tolrestat treatment prevents modification of the formalin test model of prolonged pain in hyperglycemic ratsPain, 1994
- Anti-nociceptive effects of the GM1 ganglioside derivative AGF 44 on the formalin test in normal and streptozotocin-diabetic ratsNeuroscience Letters, 1993
- Comparison of the Antinociceptive Effects of Pre- and Posttreatment with Intrathecal Morphine and MK801, an NMDA Antagonist, on the Formalin Test in the RatAnesthesiology, 1992
- Spinal opiates: a review of their effect on spinal function with emphasis on pain processingActa Anaesthesiologica Scandinavica, 1987
- Intravenous lidocaine infusion — a new treatment of chronic painful diabetic neuropathy?Pain, 1987
- Treatment of chronic painful diabetic neuropathy with intravenous lidocaine infusion.BMJ, 1986
- Efficient Analysis of Experimental ObservationsAnnual Review of Pharmacology and Toxicology, 1980